Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 85

Understand what an ALK mutation test detects in lung cancer, how tissue and liquid biopsy results are interpreted, and how ALK-positive findings guide targeted therapy.

ALK Mutation Test: Lung Cancer, Targeted Therapy, and Results

Learn what an APC genetic test can show, how positive, negative, and uncertain results are interpreted, and how FAP findings guide colon surveillance, surgery, and family testing.

APC Genetic Test: Familial Adenomatous Polyposis, Colon Cancer Risk, and Results

Understand what an ASXL1 mutation test shows in blood and bone marrow, how results relate to myeloid neoplasms and clonal hematopoiesis, and how they affect prognosis and follow-up.

ASXL1 Mutation Test: Blood Cancer, Myeloid Neoplasm, and Results

Learn what an ATM genetic test shows, how positive, negative, and uncertain results affect breast and other cancer risk, and how screening and family testing are planned.

ATM Genetic Test: Breast Cancer Risk, DNA Repair, and Results

Learn what a BAP1 genetic test shows, how results relate to melanoma, mesothelioma, and kidney cancer risk, and how surveillance and family testing are planned.

BAP1 Genetic Test: Melanoma, Mesothelioma, Kidney Cancer Risk, and Results

Understand what a BCL2 rearrangement test shows, how results support follicular lymphoma diagnosis, and why concurrent MYC and BCL2 rearrangements identify double-hit lymphoma.

BCL2 Rearrangement Test: Follicular Lymphoma, Double-Hit Lymphoma, and Results

Learn what a BCL6 rearrangement test shows, how positive and negative results are interpreted, and how BCL6, MYC, and BCL2 findings affect lymphoma classification and prognosis.

BCL6 Rearrangement Test: Lymphoma, Prognosis, and Results

Understand BCR-ABL1 testing for CML and Philadelphia-positive leukemia, including diagnostic methods, International Scale results, molecular response milestones, and resistance testing.

BCR-ABL1 Test: CML, Leukemia, Philadelphia Chromosome, and Results

Understand BRAF mutation testing in melanoma, colorectal, thyroid, and lung cancer, including V600E results, testing methods, targeted therapy, and negative-test limitations.

BRAF Mutation Test: Melanoma, Colon, Thyroid, Lung Cancer, and Results

Understand BRCA1 and BRCA2 genetic testing, cancer risks, positive, negative, and VUS results, screening, preventive surgery, treatment options, and family testing.

BRCA1 and BRCA2 Genetic Test: Cancer Risk, Mutations, and Results

Understand CALR mutation testing for high platelets, essential thrombocythemia, and primary myelofibrosis, including type 1 and type 2 results, prognosis, and follow-up.

CALR Mutation Test: Myeloproliferative Neoplasm, Platelets, and Results

Understand the CCND1/IGH fusion test for mantle cell lymphoma, including t(11;14), FISH results, cyclin D1 and SOX11 findings, prognosis, and diagnostic limits.

CCND1/IGH Fusion Test: Mantle Cell Lymphoma and Results

Understand CDH1 genetic testing, diffuse gastric and lobular breast cancer risks, positive and VUS results, expert endoscopy, preventive gastrectomy, and family testing.

CDH1 Genetic Test: Hereditary Diffuse Gastric Cancer Risk and Results

Understand CEBPA mutation testing in AML, including in-frame bZIP results, favorable-risk classification, germline familial leukemia, treatment, MRD, and test limitations.

CEBPA Mutation Test: AML Prognosis, Leukemia Genetics, and Results

Understand CHEK2 genetic test results, variant-specific breast cancer risk, changing colon guidance, prostate screening, inheritance, family testing, and next steps.

CHEK2 Genetic Test: Breast, Colon, Prostate Cancer Risk, and Results

Understand ctDNA test results for liquid biopsy profiling, targeted therapy, treatment response, molecular residual disease, recurrence risk, false negatives, and follow-up.

Circulating Tumor DNA (ctDNA) Test: Cancer Monitoring, Mutations, and Results

1...848586...137 Page 85 of 137